Mirae Asset Global Investments Co., Ltd. Dyne Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,391 shares of DYN stock, worth $70,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,391
Previous 3,785
16.01%
Holding current value
$70,431
Previous $39,000
5.13%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DYN
# of Institutions
212Shares Held
122MCall Options Held
36.5KPut Options Held
74.3K-
Ra Capital Management, L.P. Boston, MA9.71MShares$156 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$151 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$146 Million19.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.65MShares$123 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$118 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $830M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...